NumFin

InfuSystem Holdings, Inc.

符号: INFU

AMEX

7.56

USD

今天的市场价格

  • 183.7078

    市盈率

  • 13.7781

    PEG比率

  • 160.76M

    MRK市值

  • 0.00%

    DIV收益率

InfuSystem Holdings, Inc. (INFU) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 InfuSystem Holdings, Inc. (INFU). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 InfuSystem Holdings, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

balance-sheet.row.cash-and-short-term-investments

00.20.20.2
9.6
2.6
4.3
3.5
3.4
0.8
0.5
1.1
2.3
0.8
5
7.8
11.5
4
98.6
0

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98.2
0

balance-sheet.row.net-receivables

019.816.915.4
14.7
12.1
9.6
11.4
11.6
14.2
10.3
10.7
8.5
7.4
6.7
5.5
4.2
6.3
0
0

balance-sheet.row.inventory

06.44.83.9
3
2.9
2.3
1.8
2.2
1.9
1.8
1.2
1.3
3.2
1.7
0.9
0.4
0.4
0
0

balance-sheet.row.other-current-assets

04.22.92.5
2.4
1.7
1.4
1
0.9
0.9
0.6
0.5
0.7
1.6
1.9
0.5
0.7
1.3
1.3
0

balance-sheet.row.total-current-assets

030.624.822.1
29.8
19.3
17.5
17.7
20.8
20.5
15.5
15.9
14.8
13.1
15.3
14.7
16.7
11.9
100.3
0

balance-sheet.row.property-plant-equipment-net

0114848.6
44.4
43
24.9
25
30
30.2
22.3
15.3
13.9
15.8
16.7
13.5
10.9
13.5
0
0

balance-sheet.row.goodwill

03.73.73.7
0
0
0
0
0
0
0
0
0
0
64.1
56.6
56.6
56.5
0
0

balance-sheet.row.intangible-assets

07.48.410.9
11.2
15.5
19.9
24.5
31.2
31.5
25.1
24.2
25.5
28.2
33.3
28.9
30.7
32.6
0
0

balance-sheet.row.goodwill-and-intangible-assets

011.212.114.6
11.2
15.5
19.9
24.5
31.2
31.5
25.1
24.2
25.5
28.2
97.3
85.5
87.3
89.1
0
0

balance-sheet.row.long-term-investments

040.944.242
0
-0.1
0
-0.1
0
0.1
1.2
1.8
2.4
0.4
-0.5
0.7
-0.1
0
98
0

balance-sheet.row.tax-assets

016.19.610
10
0.1
0
0.1
12.4
11.5
13.8
16.3
17.8
18.2
1.1
0.1
0.1
0
0
0

balance-sheet.row.other-non-current-assets

00.1-39.4-39.8
1.7
1.5
1.7
1.7
1.9
2.5
2.5
3.9
3
0.6
0.4
0.2
1.3
1.9
-98
0.2

balance-sheet.row.total-non-current-assets

079.374.675.5
67.2
59.9
46.5
51.2
75.6
75.9
64.8
61.5
62.7
63.2
115.1
100
99.5
104.5
98
0.2

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-98
0

balance-sheet.row.total-assets

0109.999.497.6
97
79.2
64.1
68.9
96.3
96.4
80.2
77.4
77.5
76.3
130.4
114.7
116.2
116.4
100.3
0.2

balance-sheet.row.account-payables

088.37.9
6.8
8
7.1
5.5
5.3
6.6
5.2
4.7
2.1
4.1
2
1.3
1
1.1
0.4
0

balance-sheet.row.short-term-debt

01.50.90.3
9.4
8.1
4.9
3.5
8.3
5.1
6.5
5.1
4
6.6
5.6
5.5
8.6
2
0
0.1

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0

balance-sheet.row.long-term-debt-total

029.136.936.4
33.2
34.9
28.8
25.4
29.1
29.9
19
21.6
27.3
22.6
26.6
18.6
22
30.3
0
0

Deferred Revenue Non Current

0027.528.3
0
-0.1
0
0
-6.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

06.2-4.44.7
6.8
5.8
2.8
3.4
2.9
3.6
3.1
3.2
4.1
2.5
0.2
4.2
3.5
14.3
15.2
0.1

balance-sheet.row.total-non-current-liabilities

041.936.936.4
33.2
35
28.8
25.5
29.2
29.9
19
21.6
27.3
23
32.8
22.2
22.9
30.3
19.6
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

05.83.83.7
3.9
4.6
0
0.5
5.5
6.4
4.8
2.7
1.6
0
0
0
0
0
0
0

balance-sheet.row.total-liab

057.651.449.3
56.2
56.9
43.6
37.9
45.7
45.2
33.8
34.6
37.5
36.1
45.2
33.2
36.1
47.7
35.2
0.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-58.6-59.3-53.9
-44
-61.4
-62.7
-61.6
-41.1
-40
-43.7
-47.1
-48.7
-47.2
-1.8
0.1
-0.7
-10.7
-7.9
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

01.11.50.3
0
0
-42
-38.6
-34.6
-27.9
0
0
0
-0.1
-0.1
-8.5
-4.5
-0.7
0
-8.4

balance-sheet.row.other-total-stockholders-equity

0109.8105.9101.9
84.8
83.7
125.2
131.2
126.4
119.1
90.2
89.8
88.7
87.5
87
89.9
85.3
80.2
73
8.4

balance-sheet.row.total-stockholders-equity

052.34848.3
40.8
22.3
20.4
31
50.7
51.3
46.5
42.7
40
40.2
85.1
81.5
80.1
68.8
65.1
0

balance-sheet.row.total-liabilities-and-stockholders-equity

0109.999.497.6
97
79.2
64.1
68.9
96.3
96.4
80.2
77.4
77.5
76.3
130.4
114.7
116.2
116.4
100.3
0.2

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

052.34848.3
40.8
22.3
20.4
31
50.7
51.3
46.5
42.7
40
40.2
85.1
81.5
80.1
68.8
65.1
0

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

040.944.242
0
-0.1
0
-0.1
0
0.1
1.2
1.8
2.4
0.4
-0.5
0.7
-0.1
0
196.2
0

balance-sheet.row.total-debt

036.436.936.8
42.7
43
33.8
28.9
37.4
34.9
25.5
26.7
31.3
29.1
32.2
24.1
30.7
32.3
0
0.1

balance-sheet.row.net-debt

036.136.836.6
33
40.4
29.5
25.5
34
34.1
25
25.6
28.9
28.3
27.2
16.4
19.2
28.3
-0.4
0.1

现金流量表

在 InfuSystem Holdings, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

cash-flows.row.net-income

00.901.4
17.3
1.4
-1.1
-20.7
-0.2
3.7
3.4
1.7
-1.5
-45.4
-1.9
0.8
10
-2.8
-7.9
0

cash-flows.row.depreciation-and-amortization

012.513.414.6
14
12.3
11.3
12.5
10.7
8.2
6.1
8
8.4
9
8.6
6.4
6.4
0.9
6.7
0

cash-flows.row.deferred-income-tax

00.60-0.2
-10.1
0.1
-0.1
15.4
-0.2
1.8
2.6
1.2
-0.9
-23.4
-1.2
2.3
0.9
0.3
-6660153
0

cash-flows.row.stock-based-compensation

04.13.86.4
2.6
1
1
0.7
0.5
1
0.6
1.1
1
1.2
3.9
0.8
1.6
1.8
6660139
0

cash-flows.row.change-in-working-capital

0-5.60.4-2.7
-1.3
-0.2
-4.9
-5.4
-7.9
-12.8
-9.9
-9.6
-5.9
-10.3
-2.7
-4.9
-1.9
-1.7
0
0

cash-flows.row.account-receivables

0-2.4-1.20.8
-2.6
-1.6
-4.4
-5.4
-4.6
-9.1
-5.4
-8.7
-6.5
-4.9
-3.9
-1.8
-1.8
-0.7
0
0

cash-flows.row.inventory

0-1.6-0.9-0.9
-0.1
-0.6
-0.5
0.4
-0.3
-0.2
-0.5
0.1
0
-1.7
-0.5
-6.2
-3
6.3
0
0

cash-flows.row.account-payables

02.42.9-2.4
2.4
2.4
0.2
-0.4
-3.1
-2.8
-4
-1.1
-0.3
-4
2.3
-0.6
-0.6
-1.8
102885
0

cash-flows.row.other-working-capital

0-4-0.5-0.3
-0.9
-0.4
-0.2
0
0.1
-0.7
0
0.1
0.9
0.3
-0.5
3.7
3.5
-5.5
-102885
0

cash-flows.row.other-non-cash-items

0-1.5-0.1-1.3
-2.4
-0.7
5.2
5.1
5.1
5.1
4.5
5.1
4.4
76.1
4.2
4.4
-6.1
5.9
14.3
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1-15.1-16.7
-16.9
-22.6
-8.3
-3.6
-8.8
-10.2
-9.7
-6
-6.5
-5.6
-2.4
-4.6
-1.7
-0.6
0
0

cash-flows.row.acquisitions-net

04.43.6-8
4.8
3
0
0
-0.4
-6.2
0
0
0
0
-16.6
0.8
0.8
-8.7
-0.7
0

cash-flows.row.purchases-of-investments

0-10.1-14.10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-96.2
0

cash-flows.row.sales-maturities-of-investments

05.710.50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0-5.73.63.3
0
0
3.3
4.6
3.8
4.5
6.9
3.8
4
0
0
-0.8
-0.1
31.3
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-6.7-11.5-21.3
-12.2
-19.6
-5
1.1
-5.3
-11.9
-2.8
-2.2
-2.6
-5.6
-19.1
-4.6
-1
22
-97
0

cash-flows.row.debt-repayment

0-3.9-42-81.7
-37.2
-4.9
-6.3
-37.5
-67
-65.2
-66.7
-42.6
-35.5
-7.7
-23.4
-8.7
-2.1
0
0
0

cash-flows.row.common-stock-issued

01.11.41.1
0.2
0.3
0
0
0
0
0
0
0
0
0
0
0
0.5
101.7
0

cash-flows.row.common-stock-repurchased

0-1.3-6.7-1.7
-1.7
-0.7
-10.5
-0.1
-0.1
-0.2
-0.2
-0.1
-0.1
-0.5
-0.1
-0.2
0
0
0
0

cash-flows.row.dividends-paid

0-4.3-1.4-1.1
-0.2
-0.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-0.242.676.9
37.8
9.7
11.2
29
67.1
70.5
61.9
36.2
34.3
2.3
29
0.1
-0.2
-23.4
-3.4
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-4.2-6.1-6.5
-1.1
4.1
-5.6
-8.6
0
5.2
-5
-6.5
-1.4
-5.8
5.5
-8.9
-2.3
-22.9
98.3
0

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

00.10-9.5
7
-1.7
0.8
0.1
2.6
0.3
-0.6
-1.2
1.5
-4.2
-2.7
-3.8
7.6
3.5
0.4
0

cash-flows.row.cash-at-end-of-period

00.20.20.2
9.6
2.6
4.3
3.5
3.4
0.8
0.5
1.1
2.3
0.8
5
7.8
11.5
4
0.4
0

cash-flows.row.cash-at-beginning-of-period

00.20.29.6
2.6
4.3
3.5
3.4
0.8
0.5
1.1
2.3
0.8
5
7.8
11.5
4
0.4
0
0

cash-flows.row.operating-cash-flow

01117.518.3
20.3
13.9
11.4
7.6
7.9
7.1
7.3
7.5
5.5
7.2
10.8
9.7
10.9
4.4
-0.9
0

cash-flows.row.capital-expenditure

0-1-15.1-16.7
-16.9
-22.6
-8.3
-3.6
-8.8
-10.2
-9.7
-6
-6.5
-5.6
-2.4
-4.6
-1.7
-0.6
0
0

cash-flows.row.free-cash-flow

0102.41.7
3.4
-8.7
3.1
4
-0.9
-3.2
-2.5
1.5
-1.1
1.6
8.4
5.1
9.2
3.8
-0.9
0

利润表行

InfuSystem Holdings, Inc. 的收入与上期相比变化了 NaN%。据报告, INFU 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

income-statement-row.row.total-revenue

0125.8109.9102.4
97.4
81.1
67.1
71.1
70.5
72.1
66.5
62.3
58.8
54.6
47.2
39
35.4
6.6
0
0

income-statement-row.row.cost-of-revenue

064.847.342.2
38.6
34.2
28.1
27.7
25.8
20.9
19.1
18.6
15.9
19.3
13.7
10.3
9.2
1.6
0
0

income-statement-row.row.gross-profit

06162.660.2
58.8
46.9
39
43.4
44.7
51.2
47.4
43.7
42.9
35.4
33.5
28.6
26.2
5
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-0.12.64.3
5.1
4.4
0
-0.1
0
0
0
0.3
-0.1
6.8
6.8
5.8
5
6.5
20.8
0

income-statement-row.row.operating-expenses

056.960.957.4
49.9
43.4
38.6
46.2
43.8
42.3
38
37.8
40.9
34.1
34.5
23.3
21.4
6.5
20.8
0

income-statement-row.row.cost-and-expenses

0121.7108.399.6
88.6
77.6
66.7
73.9
69.5
63.3
57.2
56.4
56.8
53.4
48.2
33.6
30.6
8.1
20.8
0

income-statement-row.row.interest-income

001.41.4
1.3
1.9
0
0
0
0
0
0
0
0
0
0
0
3.9
3.2
0

income-statement-row.row.interest-expense

02.21.41.4
1.3
1.9
1.4
1.3
1.3
1.7
3.1
3.5
3.3
2.2
3.4
3.5
3.8
0.8
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-2.2-1.5-1.6
-1.3
-2
0
-1.1
0
-1.6
0
0.3
-0.8
-67.6
1.1
-0.1
9.8
-3.3
10.8
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-0.12.64.3
5.1
4.4
0
-0.1
0
0
0
0.3
-0.1
6.8
6.8
5.8
5
6.5
20.8
0

income-statement-row.row.total-operating-expenses

0-2.2-1.5-1.6
-1.3
-2
0
-1.1
0
-1.6
0
0.3
-0.8
-67.6
1.1
-0.1
9.8
-3.3
10.8
0

income-statement-row.row.interest-expense

02.21.41.4
1.3
1.9
1.4
1.3
1.3
1.7
3.1
3.5
3.3
2.2
3.4
3.5
3.8
0.8
0
0

income-statement-row.row.depreciation-and-amortization

012.513.214.4
14
12.2
11.3
12.5
10.7
8.2
6.1
8
8.4
9
8.6
6.4
6.4
0.9
6.7
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

04.11.72.8
8.8
3.5
0.4
-3.8
1
8.9
9.3
5.9
2
-66.4
-0.9
5.3
4.8
-1.5
-20.8
0

income-statement-row.row.income-before-tax

01.90.11.3
7.5
1.5
-1
-5.3
-0.4
5.6
6.2
2.7
-2.2
-68.6
-3.2
1.8
10.9
-1.7
-6.8
0

income-statement-row.row.income-tax-expense

010.1-0.2
-9.8
0.2
0.1
15.4
-0.1
1.8
2.9
1
-0.7
-23.1
-1.4
1
0.9
1.1
1
0

income-statement-row.row.net-income

00.901.4
17.3
1.4
-1.1
-20.7
-0.2
3.7
3.4
1.7
-1.5
-45.4
-1.9
0.8
10
-2.8
-7.9
0
类似股票
您可能还对以下内容感兴趣：
CNVVF
ConvaTec Group Plc.
3.2 USD
PNK
300753.SZ
Jiangsu Apon Medical Technology Co., Ltd..
13.2 CNY
SHZ
BLCO
Bausch + Lomb Corporation.
15.29 USD
NYSE
137310.KS
SD BioSensor, Inc.
10740 KRW
KSC
YPHDF
Ypsomed Holding AG.
362 USD
PNK
688289.SS
Sansure Biotech Inc..
20.69 CNY
SHH
7780.T
Menicon Co., Ltd..
1516.5 JPY
JPX
ALC.SW
Alcon Inc..
72.94 CHF
SIX
8086.T
Nipro Corporation.
1256 JPY
JPX
6929.HK
OrbusNeich Medical Group Holdings Limited.
4.42 HKD
HKSE

常见问题

什么是 InfuSystem Holdings, Inc. (INFU) 总资产是多少？

InfuSystem Holdings, Inc. (INFU) 总资产为 109885000.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.508.

什么是公司自由现金流？

自由现金流为 0.069.

什么是企业净利润率？

净利润率为 0.007.

企业总收入是多少？

总收入为 0.032.

什么是 InfuSystem Holdings, Inc. (INFU) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 872000.000.

公司总债务是多少？

债务总额为 36374000.000.

营业费用是多少？

运营支出为 56931000.000.

公司现金是多少？

企业现金为 0.000.